Home
Conditions
Nevi and Melanomas

Clinical trial condition

Nevi and Melanomas

Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.

2,363 public trials 405 recruiting studies

Refine in advanced search Browse all conditions

Nevi and Melanomas trial results

Completed

Melanoma Biomarker Study

NCT00348088

Conditions: Melanoma, Metastatic Melanoma, Neoplasm Metastasis, +14 more
Locations: Johns Hopkins University - Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States

View Trial Details

Completed

A Clinical Study, to Evaluate the Safety and Tolerability of Intradermal IMM-101 in Adult Melanoma Cancer Patients

NCT01308762

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: HCA Clinical Trials Unit, 79 Harley Street, London, United Kingdom

View Trial Details

Completed

Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 Expression

NCT00835419

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: University of Newcastle, School of Medicine and Public Health Newcastle, New South Wales, Australia

Mater Adult Hospital Raymond Tce South Brisbane, QLD 4101 Brisbane, Australia

Peninsula Oncology Centre Frankston, Australia

John Fawkner Cancer Trial Centre Victoria, Australia

View Trial Details

Completed

Cyclophosphamide and Fludarabine Followed by Cellular Adoptive Immunotherapy and Vaccine Therapy in Patients With Metastatic Melanoma

NCT00324623

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland

View Trial Details

Completed

Comparative Microarray Analysis in Primary Cutaneous Malignant Melanoma

NCT01482260

Conditions: Cutaneous Malignant Melanoma, Melanoma, Melanoma, Cutaneous Malignant, +11 more
Locations: Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum Bochum, North Rhine-Westphalia, Germany

View Trial Details

Completed

Natural Killer Cells Plus IL-2 Following Chemotherapy to Treat Advanced Melanoma or Kidney Cancer

NCT00328861

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +20 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Completed

Peptide Vaccination for Patients at High Risk for Recurrent Melanoma

NCT00059475

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Completed

Evaluation of the Impact of Adjuvants Accompanying Peptide Immunization in High-Risk Melanoma

NCT00273910

Conditions: High-Risk Melanoma, Melanoma, Neoplasms, +10 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Completed

Chemotherapy, Irradiation, Cell Infusions, and Interleukin-2 to Treat Metastatic Melanoma

NCT00314106

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Completed

Immunohistochemical Expression Patterns of microRNA Processing Enzyme Dicer in Cutaneous Malignant Melanoma, Benign and Dysplastic Melanocytic Naevi

NCT00862914

Conditions: Malignant Melanoma, Melanoma, Naevi, +13 more
Locations: Department of Dermatology and Allergology, Ruhr-University Bochum Bochum, North Rhine-Westphalia, Germany

View Trial Details

Nevi and Melanomas

Nevi and Melanomas trial results

Related conditions